Project description
Heart valve replacement surgery could soon be much safer in the long run
The aorta is a very large blood vessel that acts as a conduit for oxygenated blood leaving the left ventricle on its way to the rest of the body. When the aortic valve narrows (aortic stenosis), your heart must work harder. This weakens the heart muscle, increases intracardial blood pressure, and eventually can even cause a heart attack. Transcatheter aortic valve implantation (TAVI) places a replacement valve without removing the damaged one. The downside of this minimally invasive surgery is the potential for dislodged tissue and debris entering the circulation with potentially dire consequences. CAPTIS has developed a device that can remove embolic particles during surgery. EU funding is supporting clinical trials and regulatory approval for commercialisation.
Objective
Aortic stenosis (AS) is the most common and most severe heart valve disease, affecting 20 million people worldwide. For
patients with severe AS, the most common treatment is valve replacement through Transcatheter Aortic Valve Implantation
(TAVI). The procedure is very risky, since embolic debris are released to the blood stream and may reach the brain and
other organs, reducing or blocking the blood flow. Strikingly, embolic debris cause new ischemic brain lesions in 70% of
patients post TAVI, major disabling strokes in 9%, and kidney dysfunction 12.3% of cases. Embolic Protection Devices
(EPDs) are being developed to reduce the risk posed by embolic debris during TAVI. To date, only one EPD has been
commercialised for use in TAVI procedure. Unfortunately, the device is poorly effective since it can only provide partial
cerebral protection, interferes with the TAVI delivery system, and requires secondary artery access to the TAVI system, thus
increasing procedure time and posing the patient at a higher risk of post-operative side effects.
Filterlex developed the CAPTIS® system, an innovative intra-aortic Embolic Protection Device (EPD) for deflecting,
capturing and removing embolic particles during TAVI procedure. Easily positioned, deployed and retrieved through the
same TAVI artery access, this revolutionary EPD provides full-body protection by ensuring the best performance in capturing
and safely removing the embolic debris released during TAVI. In this way, CAPTIS strongly reduces the risk of stroke and
ischemia to other vital organs.
The key objectives of the project are to validate safety and efficacy of the CAPTIS system through a First-In-Human clinical
trial and multi-site clinical trial, and to obtain CE mark certification for commercialisation in Europe.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-2 - SME instrument phase 2
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
3089900 CAESAREA
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.